Your browser doesn't support javascript.
loading
Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of Amphetamine Extended-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder.
Cutler, Andrew J; Childress, Ann C; Pardo, Antonio; Duhoux, Stéphanie; Gomeni, Roberto; Rafla, Eman; King, Thomas R; Kando, Judith C.
Affiliation
  • Cutler AJ; Neuroscience Education Institute, Lakewood Ranch, Florida.
  • Childress AC; Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York.
  • Pardo A; Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, Nevada.
  • Duhoux S; Tris Pharma, Inc., Monmouth Junction, New Jersey.
  • Gomeni R; Tris Pharma, Inc., Monmouth Junction, New Jersey.
  • Rafla E; Corresponding author: Stéphanie Duhoux, PhD, Tris Pharma, Inc., Medical Affairs, 2033 US 130, Monmouth Junction, NJ 08852 (sduhoux@trispharma.com).
  • King TR; PharmacoMetrica, La Fouillade, France.
  • Kando JC; Tris Pharma, Inc., Monmouth Junction, New Jersey.
J Clin Psychiatry ; 83(5)2022 07 20.
Article in En | MEDLINE | ID: mdl-35857716
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Central Nervous System Stimulants Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans Language: En Journal: J Clin Psychiatry Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Central Nervous System Stimulants Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans Language: En Journal: J Clin Psychiatry Year: 2022 Document type: Article Country of publication: United States